Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Recent publications

Publication

Regulation Around the World: Open Finance

In this issue of Regulation Around the World we look at how regulators are developing their proposals for Open Finance.

Global | July 07, 2025

Financial services and regulation
London skyscrapers

Publication

Essential Corporate News – Week ending 4 July 2025

On 3 July 2025 the UK Takeover Panel (Panel) published PCP 2025/1: Dual class share structures, IPOs and share buybacks (Consultation) setting out a proposed framework for the application of the UK Takeover Code (Code) to companies with dual class share structures (DCSS companies).

United Kingdom | July 04, 2025

Corporate, M&A and securities

Publication

Singapore Court of Appeal rules on moratorium carve-outs and the interactions between arbitration and insolvency regimes

In Sapura Fabrication Sdn Bhd and others v GAS and anor appeal [2025] SGCA 13, the Singapore Court of Appeal made important findings

Global | July 04, 2025

International arbitration
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now